Home / Medical Devices / Vascular Grafts Market By Type (Endovascular Stent Grafts, Peripheral Vascular Grafts, Hemodialysis Access Grafts, Coronary Artery By-Pass Grafts), By Material (Synthetic, Biological, Biosynthetic), By Application (Cardiovascular Diseases, Aneurysm, Kidney Failure, Vascular Occlusion) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Vascular Grafts Market By Type (Endovascular Stent Grafts, Peripheral Vascular Grafts, Hemodialysis Access Grafts, Coronary Artery By-Pass Grafts), By Material (Synthetic, Biological, Biosynthetic), By Application (Cardiovascular Diseases, Aneurysm, Kidney Failure, Vascular Occlusion) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

Published: Jul 2017 | Report Code: 58546-07-17

The purpose of this research study titled ‘Vascular Grafts Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global vascular grafts market. This report presents and analyzes the major trends prevalent in the global vascular grafts market and the market size and forecast.

This report categorizes the global vascular grafts market in terms of type, material, application and geographical distribution. Based on product type, the global vascular grafts market is categorized into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, and coronary artery by-pass graft. Synthetic (polytetrafluethylene (PTFE), polyurethane (PU), dacron, and others), biological (saphenous vein, bovine vein and others) and biosynthetic are the various vascular grafts materials studied in this report. In terms of application areas, vascular grafts find wide usage in treatment for cardiovascular diseases, aneurysm, kidney failure, vascular occlusion and diabetes. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global vascular grafts market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of type, material, applications and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global vascular grafts market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the vascular grafts market. The key players profiled in this report are Artegraft, Inc., B. Braun Melsungen AG, Cook Medical, Inc., C.R. Bard, Inc., CryoLife, Inc., Heart Medical Europe BV, Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd), LeMaitre Vascular, Inc., MAQUET Holding B.V. & Co. KG, Medtronic plc, Shanghai Suokang Medical Implants Co. Ltd., Terumo Medical Corporation, Vascular Grafts Solutions Ltd., Vascutek Ltd. and W. L. Gore & Associates, Inc.

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Vascular Grafts Market Portraiture
2.1.1. Global Vascular Grafts Market, by Type, 2016
2.1.2. Global Vascular Grafts Market, by Material, 2016
2.1.3. Global Vascular Grafts Market, by Application, 2016
2.1.4. Global Vascular Grafts Market, by Geography, 2016

Chapter 3. Vascular Grafts Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Prevalence Data of Major Target Diseases (Coronary Artery Disease, Diabetes, ESRD, & Chronic Kidney Diseases)
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Porter’s Five Forces Analysis
3.7. Attractive Investment Proposition, by Geography
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition: Global Vascular Grafts Market, by Type
4.3. Endovascular Stent Grafts
4.4. Peripheral Vascular Grafts
4.5. Hemodialysis Access Grafts
4.6. Coronary Artery By-pass Grafts

Chapter 5. Global Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Vascular Grafts Market, by Material
5.2. Synthetic
5.2.1. Polytetrafluethylene (PTFE)
5.2.2. Polyurethane (PU)
5.2.3. Dacron
5.2.4. Others
5.3. Biological
5.3.1. Saphenous Vein
5.3.2. Bovine Vein
5.3.3. Others
5.4. Biosynthetic

Chapter 6. Global Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global Vascular Grafts Market, by Application
6.2. Cardiovascular Diseases
6.3. Aneurysm
6.4. Kidney Failure
6.5. Vascular Occlusion
6.6. Diabetes

Chapter 7. Global Vascular Grafts Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Vascular Grafts Market Analysis, 2015 – 2025
7.2.1. North America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.2.3. North America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.2.4. North America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Vascular Grafts Market Analysis, 2015 – 2025
7.3.1. Europe Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.3.3. Europe Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.3.4. Europe Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. France
7.3.4.4. Rest of Europe
7.4. Asia Pacific Vascular Grafts Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. India
7.4.4.4. Rest of APAC
7.5. Latin America Vascular Grafts Market Analysis, 2015 – 2025
7.5.1. Latin America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Vascular Grafts Market Analysis, 2015 – 2025
7.6.1. MEA Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
7.6.3. MEA Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
7.6.4. MEA Vascular Grafts Market, by Region, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Artegraft, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. B. Braun Melsungen AG
8.3. Cook Medical, Inc.
8.4. C.R. Bard, Inc.
8.5. CryoLife, Inc.
8.6. Heart Medical Europe BV
8.7. Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd)
8.8. LeMaitre Vascular, Inc.
8.9. MAQUET Holding B.V. & Co. KG
8.10. Medtronic plc
8.11. Shanghai Suokang Medical Implants Co. Ltd.
8.12. Terumo Medical Corporation
8.13. Vascular Grafts Solutions Ltd.
8.14. Vascutek Ltd.
8.15. W. L. Gore & Associates, Inc.
8.16. Other Notable Players

List Of Table :

TABLE 1 Global Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 3 Global Synthetic Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 4 Global Biological Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 5 Global Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 6 Global Vascular Grafts Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 7 North America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 8 North America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 9 North America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 10 North America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 13 Europe Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Vascular Grafts Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Vascular Grafts Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa Vascular Grafts Market, by Material, 2015 – 2025 (US$ Mn)
TABLE 25 Middle East and Africa Vascular Grafts Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East and Africa Vascular Grafts Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 27 Artegraft, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 B. Braun Melsungen AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Cook Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 C.R. Bard, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Heart Medical Europe BV: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd): Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 LeMaitre Vascular, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 MAQUET Holding B.V. & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Medtronic plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 Shanghai Suokang Medical Implants Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 Terumo Medical Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 39 Vascular Grafts Solutions Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 40 Vascutek Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 41 W. L. Gore & Associates, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List Of Figures :

FIG. 1 Vascular Grafts: Market Segmentation
FIG. 2 Global Vascular Grafts Market Share, by Type, 2016 (Value %)
FIG. 3 Global Vascular Grafts Market Share, by Material, 2016 Vs. 2025 (Value %)
FIG. 4 Global Vascular Grafts Market, by Application, 2016 (US$ Mn)
FIG. 5 Global Vascular Grafts Market, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Endovascular Stent Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 9 Global Peripheral Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 10 Global Hemodialysis Access Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 11 Global Coronary Artery By-pass Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 12 Global Polytetrafluethylene (PTFE) Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 13 Global Polyurethane (PU) Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 14 Global Dacron Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Synthetic Material Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 16 Global Saphenous Vein Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 17 Global Bovine Vein Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 18 Global Other Biological Materials Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 19 Global Biosynthetic Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 20 Global Vascular Grafts for Cardiovascular Diseases Market, 2015 – 2025 (US$ Mn)
FIG. 21 Global Vascular Grafts for Aneurysm Market, 2015 – 2025 (US$ Mn)
FIG. 22 Global Vascular Grafts for Kidney Failure Market, 2015 – 2025 (US$ Mn)
FIG. 23 Global Vascular Grafts for Vascular Occlusion Market, 2015 – 2025 (US$ Mn)
FIG. 24 Global Vascular Grafts for Diabetes Market, 2015 – 2025 (US$ Mn)
FIG. 25 U.S. Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 26 Canada Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 27 U.K. Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 28 Germany Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 29 France Vascular Grafts Market, 2015-2025 (US$ Mn)
FIG. 30 Rest of Europe Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 31 Japan Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 32 China Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 33 India Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 34 Rest of Asia Pacific Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 35 Brazil Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 36 Mexico Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 37 Rest of Latin America Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 38 GCC Vascular Grafts Market, 2015 – 2025 (US$ Mn)
FIG. 39 Rest of Middle East and Africa Vascular Grafts Market, 2015 – 2025 (US$ Mn)

The global vascular grafts market is studied for the following graft types:

  • Endovascular Stent Grafts
  • Peripheral Vascular Grafts
  • Hemodialysis Access Grafts
  • Coronary Artery By-pass Grafts

Vascular Grafts Market

In 2016, endovascular stent grafts occupied the largest share of the overall vascular grafts market. Major factors influencing its dominance include growing risk of chronic diseases such as renal conditions, cardiovascular diseases and diabetes due to lifestyle changes, occupational factors and dietary habits. Furthermore, growing prevalence of hypertension and age-related chronic conditions has additionally urged the need for endovascular grafts and coronary artery by-pass grafts in the market. Additionally, recent development in vascular tissue engineering has resulted in creation of cell-free grafts that are available on demand. However, restraints associated with cell-based grafts such as cell expansion, long-term bioreactor culture and cell sourcing has motivated introduction of completely cell-free vascular grafts.

The global vascular grafts market is studied for the following application areas:

  • Cardiovascular Diseases
  • Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Diabetes

Vascular Grafts Market

In 2016, cardiovascular diseases accounted for over 20% of the global vascular grafts market on account of growing prevalence of hypertension, and other age-related cardiovascular diseases, with the highest prevalence of coronary artery diseases. Cardiovascular diseases are often associated with blockage or narrowing of blood vessels and reduced blood flow. It is predicted that the by 2032, CVD mortality will cross 23 Mn mark. Vascular surgery is often recommended for treatment of CVDs when pharmaceutical administration, and dietary and lifestyle modifications prove inadequate. Vascular grafts may be used to bypass or replace damaged vessel. At present, most favored conduits for cardiovascular grafting are autologous arteries or veins, saphenous vein being the most common autograft option. Despite being the gold standard for grafting, saphenous vein grafting presents limited patency. Additionally, synthetic vascular grafts though available as an alternative to autologous grafts are used less due to poor patency rates.

Geographically, the global vascular grafts market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Vascular Grafts Market

North America is the largest regional market for vascular grafts and will continue to dominate the global market. High prevalence of chronic diseases such as diabetes, cardiovascular diseases and end-stage renal diseases and the corresponding growth in demand for surgical treatments largely contribute to the domination of North America market. Existence of developed healthcare system, favorable reimbursements and greater awareness about treatment and management of chronic diseases are major features of North America market. Additionally, Asia Pacific is anticipated to be the fastest processing market for vascular grafts during the forecast period. Rapid evolution of healthcare systems and growing penetration of major market players in the light of increasing healthcare expenditure greatly attribute to the movement of Asia Pacific market.

The detailed regional classification of the global vascular grafts market is as follows:

  • North America (U.S. & Canada)
  • Europe (Germany, U.K., France and Rest of Europe)
  • Asia Pacific (China, India, Japan and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)

The global vascular grafts market is studied for the following material types:

  • Synthetic    
    • Polytetrafluethylene (PTFE)
    • Polyurethane (PU)
    • Dacron
    • Others
  • Biological    
    • Saphenous Vein
    • Bovine Vein
    • Others
  • Biosynthetic

Vascular Grafts Market

At present synthetic grafts are observed to be the most preferred type worldwide. Polytetrafluethylene, Polyurethane, Dacron, etc. are highly preferred in a majority of grafting procedures. Easy availability, lesser cost, higher tensile strength are some of the factors attributing to larger market share of synthetic materials. However, biological materials have higher demand in cardiovascular treatments and are expected to be the fastest growing segment. Growing awareness about benefits of biological grafts in terms of acceptance, biocompatibility and technological advancement are the key factors contributing to the emergence of biological materials. At present internal thoracic artery and saphenous vein are the gold standard grafts used for cardiovascular procedures are outperform synthetic alternatives. However, limited availability of these grafts challenge their widespread use. To address this challenge, tissue-engineered vascular grafts (TEVG) are being rigorously explored. TEVG have offered benefits such as ability to remodel, grow and repair in-vivo without needing autograft surgery.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients